Table 3.

Comparing patient‐reported and clinical factors between high and low composite adherence

	Total (n = 121)	Composite Adherence		P value
		High (n = 46)	Low (n = 75)
Hurried communication, a median[IQR]	1.3[1‐1.8]	1[1‐1.5]	1.3[1‐1.8]	0.03
Hard words, median[IQR]	1[1‐2]	1[1‐2]	2[1‐2]	0.03
Compassionate respectful, a median[IQR]	5[4.2‐5]	5[5‐5]	5[4‐5]	0.06
Compassionate, median[IQR]	5[4‐5]	5[5‐5]	5[4‐5]	0.05
Self‐efficacy in taking meds, b median[IQR]	48[42‐56]	51[46‐61]	47[41‐55]	0.08
Anxiety, b median[IQR]	52[40‐58]	51[40‐56]	53[40‐60]	0.05
Pain intensity, c mean (SD)	4 (2.6)	3.6 (2.8)	4.3 (2.5)	0.09
>2 SLE medications	70%	51%	81%	0.001
SLE regimen complexity, median[IQR]	7[3‐9]	5[3‐8]	8[5‐10]	0.02
SLICC damage score, median[IQR]	2[0‐3]	1[0‐2]	2[1‐4]	0.02
SLAQ, median[IQR]	9[5‐14]	6[4‐12]	9[7‐15]	0.01
SLEDAI, median[IQR]	2[0‐5]	0.5[0‐4]	2[0‐6]	0.08
≥1 ER visit/hospitalization	58%	46%	65%	0.03
SLE disease duration, y, median[IQR]	15[8‐21]	14[9‐18]	15[8‐21]	1.0

Abbreviation: ER, emergency room; IPC‐29, Interpersonal Processes of Care Survey with 29 questions; IQR, interquartile range; meds, medications; PROMIS, Patient‐Reported Outcomes Measurement Information System; SD, standard deviation; SLAQ, Systemic Lupus Activity Questionnaire, SLE, systemic lupus erythematosus, SLEDAI, SLE Disease Activity Index, SLICC, Systemic Lupus International Collaborating Clinics.

^aIPC‐29 survey, score ranges from 1 to 5; 1 is the best score for hurried communication, 5 is the best score for compassionate respectful, other domains (elicited concerns, explained results, patient‐centered decision making, discrimination, and disrespectful office staff) were nonsignificant.

^bPROMIS measures, reference population mean score is 50, clinically significant difference is 5, higher score indicates more of the domain.

^cPart of PROMIS‐29, score ranges from 0 to 10, with 10 indicating most severe pain.

Bolded values indicate p‐value <0.05.